Medical marijuana maker R&D tax break as CEO steps down
Australian medical marijuana manufacturer Cann Group has received a $4.3 million tax incentive rebate for its R&D into medicinal cannabis. The rebate relates to its in-house research activities as well as activities conducted through its work with key partners. This work includes recent clinical trials of its low-dose CBD capsules’ efficacy in reducing short-term sleep…